Step 5: preparation of intermediate 10-Allyloxy-5-(3-hydroxy-propyl)-3-thia-5,8,10-triaza-tricyclo[6.2.1.02,6]undec-2(6)-ene-4,9-dione (10e)
Using the procedure described in example 3 (step 11), tert-butyl 7-(allyloxyamino)-3-[3-[tert-butyl(dimethyl)silyl]oxypropyl]-2-oxo-6,7-dihydro-4H-thiazolo[4,5-c]pyridine-5-carboxylate (10d) (512 mg, 1.02 mmol) was converted to 10-allyloxy-5-(3-hydroxy-propyl)-3-thia-5,8,10-triaza-tricyclo[6.2.1.02,6]undec-2(6)-ene-4,9-dione (10e) (219 mg, 0.70 mmol, 69%) after a purification on silica gel (DCM/Acetone 100/0 to 60/40).